BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15447663)

  • 1. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
    Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
    J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.
    Shimura H; Schwartz D; Gygi SP; Kosik KS
    J Biol Chem; 2004 Feb; 279(6):4869-76. PubMed ID: 14612456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes.
    Choi JS; Cho S; Park SG; Park BC; Lee DH
    Biochem Biophys Res Commun; 2004 Aug; 321(3):574-83. PubMed ID: 15358145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
    Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
    J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes.
    Saidi LJ; Polydoro M; Kay KR; Sanchez L; Mandelkow EM; Hyman BT; Spires-Jones TL
    J Alzheimers Dis; 2015; 44(3):937-47. PubMed ID: 25374103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The U-box ligase carboxyl-terminus of Hsc 70-interacting protein ubiquitylates Epsin.
    Timsit YE; Miller SL; Mohney RP; O'Bryan JP
    Biochem Biophys Res Commun; 2005 Mar; 328(2):550-9. PubMed ID: 15694383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHIP: a quality-control E3 ligase collaborating with molecular chaperones.
    Murata S; Chiba T; Tanaka K
    Int J Biochem Cell Biol; 2003 May; 35(5):572-8. PubMed ID: 12672450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation.
    Jiang J; Ballinger CA; Wu Y; Dai Q; Cyr DM; Höhfeld J; Patterson C
    J Biol Chem; 2001 Nov; 276(46):42938-44. PubMed ID: 11557750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70.
    Urushitani M; Kurisu J; Tateno M; Hatakeyama S; Nakayama K; Kato S; Takahashi R
    J Neurochem; 2004 Jul; 90(1):231-44. PubMed ID: 15198682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
    Fan M; Park A; Nephew KP
    Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.
    Dickey CA; Yue M; Lin WL; Dickson DW; Dunmore JH; Lee WC; Zehr C; West G; Cao S; Clark AM; Caldwell GA; Caldwell KA; Eckman C; Patterson C; Hutton M; Petrucelli L
    J Neurosci; 2006 Jun; 26(26):6985-96. PubMed ID: 16807328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
    Tateishi Y; Kawabe Y; Chiba T; Murata S; Ichikawa K; Murayama A; Tanaka K; Baba T; Kato S; Yanagisawa J
    EMBO J; 2004 Dec; 23(24):4813-23. PubMed ID: 15538384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
    Huang Z; Nie L; Xu M; Sun XH
    Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHIP: a link between the chaperone and proteasome systems.
    McDonough H; Patterson C
    Cell Stress Chaperones; 2003; 8(4):303-8. PubMed ID: 15115282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.
    Petrucelli L; Dickson D; Kehoe K; Taylor J; Snyder H; Grover A; De Lucia M; McGowan E; Lewis J; Prihar G; Kim J; Dillmann WH; Browne SE; Hall A; Voellmy R; Tsuboi Y; Dawson TM; Wolozin B; Hardy J; Hutton M
    Hum Mol Genet; 2004 Apr; 13(7):703-14. PubMed ID: 14962978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein.
    Bonvini P; Dalla Rosa H; Vignes N; Rosolen A
    Cancer Res; 2004 May; 64(9):3256-64. PubMed ID: 15126367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism.
    Kumar P; Ambasta RK; Veereshwarayya V; Rosen KM; Kosik KS; Band H; Mestril R; Patterson C; Querfurth HW
    Hum Mol Genet; 2007 Apr; 16(7):848-64. PubMed ID: 17317785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins.
    Connell P; Ballinger CA; Jiang J; Wu Y; Thompson LJ; Höhfeld J; Patterson C
    Nat Cell Biol; 2001 Jan; 3(1):93-6. PubMed ID: 11146632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
    Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
    J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.